IL24 and hepatocellular carcinoma: ZD55-HAb18-IL24 inhibited HCC cell growth to a greater extent than either ZD55-HAb18 or ZD55-IL24 alone (Figure 3B-3F), indicating ZD55-HAb18-IL24 had higher antitumor efficacy.